GLOBAL BLOOD THERAPEUTICS IN's ticker is and the CUSIP is 37890U908. A total of 5 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $923,000 | -49.6% | 213 | -26.6% | 0.03% | -72.8% |
| Q2 2020 | $1,831,000 | +435.4% | 290 | +332.8% | 0.12% | +346.4% |
| Q1 2020 | $342,000 | -77.5% | 67 | -64.9% | 0.03% | -78.8% |
| Q4 2019 | $1,518,000 | -28.3% | 191 | -56.2% | 0.13% | -32.0% |
| Q3 2019 | $2,116,000 | -7.8% | 436 | 0.0% | 0.19% | -7.2% |
| Q2 2019 | $2,294,000 | +47.4% | 436 | +48.3% | 0.21% | +38.4% |
| Q1 2019 | $1,556,000 | +70.8% | 294 | +32.4% | 0.15% | +13.5% |
| Q4 2018 | $911,000 | +5.2% | 222 | -2.6% | 0.13% | +54.7% |
| Q3 2018 | $866,000 | -58.6% | 228 | -50.8% | 0.09% | -52.7% |
| Q2 2018 | $2,093,000 | – | 463 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 1,312 | $4,986,000 | 0.64% |
| BOOTHBAY FUND MANAGEMENT, LLC | 228 | $866,000 | 0.09% |
| GROUP ONE TRADING, L.P. | 124,400 | $4,727,000 | 0.04% |
| SIMPLEX TRADING, LLC | 421 | $1,599,000 | 0.01% |
| JPMORGAN CHASE & CO | 149,900 | $5,696,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |